Will Manufacturers Using UK Notified Bodies Have Post-Brexit Disadvantage?
Executive Summary
More and more details are emerging about the likely impact of Brexit, as MedTech Europe shows in its newly publicized position paper. Will some companies even come to regret hiring UK notified bodies?
You may also be interested in...
EU Commission May Be Swamped As Notified Bodies Race To Start Line
It is nearly six months since the EU's Medical Device and IVD Regulations entered into force. In 10 days' time, on Nov. 26, notified bodies can apply to be designated under the new rules. More are ready than expected. Can the European Commission cope?
UK's Brexit Article 50 Talks Will Tackle Health Care In December
The European industry association MedTech Europe (MTE) issued its Brexit position paper last week, in good time for the UK's article 50 negotiators to heed its warnings about the fall-out that a "hard Brexit," in which the UK emerges from the talks with no trade deal, could have on the business of health care and patient well-being, in the UK and beyond.
ABHI 2017: Hopes, Fears And Opportunities On UK Medtech Agenda
Securing market access at a time of an unprecedented budget squeeze, driving forward with medtech and digital innovation plans and maintaining barrier-free access to the EU market: these are the uppermost thoughts on the minds of UK medtech bosses. It's hard, but it's not mission impossible, industry and government leaders said at the ABHI's 2017 UK Market Conference.